Stockley's drug interactions : a source book of interactions, their mechanisms, clinical importance and management / edited by Claire L. Preston, BPharm, PGDipMedMan, MRPharmS
Medienart: |
Buch |
---|
Erscheinungsjahr: |
[2019] © 2019 |
---|---|
Erschienen: |
London: PhP, Pharmaceutical Press ; 2019 © 2019 |
Ausgabe: |
Twelfth edition |
Sprache: |
Englisch |
---|
WorkTitle: | |
---|---|
Weiterer Titel: |
Drug interactions |
Beteiligte Personen: |
Preston, Claire L. [HerausgeberIn] |
---|
ISBN: |
---|
BKL: | |
---|---|
Themen: |
RVK: |
---|
Umfang: |
vii, 2040 Seiten |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1681556979 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1681556979 | ||
003 | DE-627 | ||
005 | 20230426213211.0 | ||
007 | tu | ||
008 | 191111s2019 xxk||||| 00| ||eng c | ||
020 | |a 9780857113474 |9 978-0-85711-347-4 | ||
035 | |a (DE-627)1681556979 | ||
035 | |a (DE-599)KXP1681556979 | ||
035 | |a (OCoLC)1195553502 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XA-GB | ||
084 | |a VS 5800 |q DE-14/sred |2 rvk |0 (DE-625)rvk/147694:253 | ||
084 | |a XI 2000 |q DE-14/sred |2 rvk |0 (DE-625)rvk/152980:12905 | ||
084 | |a 44.40 |2 bkl | ||
130 | 0 | |a Drug interactions | |
245 | 1 | 0 | |a Stockley's drug interactions |b a source book of interactions, their mechanisms, clinical importance and management |c edited by Claire L. Preston, BPharm, PGDipMedMan, MRPharmS |
246 | 3 | 3 | |a Drug interactions |
250 | |a Twelfth edition | ||
264 | 1 | |a London |b PhP, Pharmaceutical Press |c [2019] | |
264 | 4 | |c © 2019 | |
300 | |a vii, 2040 Seiten | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
689 | 0 | 0 | |D s |0 (DE-588)4045687-0 |0 (DE-627)104791454 |0 (DE-576)209066377 |a Pharmakologie |2 gnd |
689 | 0 | |5 (DE-627) | |
700 | 1 | |a Preston, Claire L. |e herausgeberin |4 edt | |
700 | 1 | |a Stockley, Ivan H. |e begründerin eines werks |0 (DE-588)13741126X |0 (DE-627)592618196 |0 (DE-576)175494940 |4 oth | |
912 | |a GBV_ILN_65 | ||
912 | |a ISIL_DE-3 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_65_a004 | ||
912 | |a GBV_ILN_2002 | ||
912 | |a ISIL_DE-21-123 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a ISIL_DE-14 | ||
936 | r | v | |a VS 5800 |b Allgemeines |k Chemie und Pharmazie |k Pharmazeutische Chemie und Molekularpharmakologie |k Pharmazeutische Chemie und Molekularpharmakologie allgemein |k Arzneimittelwechselwirkung |k Allgemeines |0 (DE-627)1271709686 |0 (DE-625)rvk/147694:253 |0 (DE-576)201709686 |
936 | r | v | |a XI 2000 |b Allgemeines |k Medizin |k Pharmakologie und Toxikologie |k Allgemeine Pharmakologie |k Arzneimittelnebenwirkung, iatrogene Krankheit |k Allgemeines |0 (DE-627)1271500116 |0 (DE-625)rvk/152980:12905 |0 (DE-576)201500116 |
936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |0 (DE-627)106423304 |
951 | |a BO | ||
980 | |2 65 |1 01 |x 3/4 |b 3538885605 |c 00 |f Ha 4-HA |d VS 5800 112<12> |e c |j --%%-- |c 09 |f Ha 4 |d VS 5800 112<12> |e --%%-- |j --%%-- |y ka004 |z 09-12-19 | ||
980 | |2 2002 |1 01 |x DE-21-123 |b 3949436049 |c 00 |f Bibliothek (bei der Aufsicht verlangen) |d T phakol 30-2019-1 |e p |j --%%-- |k Ausleihe nur über Bibliothekspersonal möglich |y l01 |z 13-07-21 | ||
980 | |2 2006 |1 01 |x DE-14 |b 3733542460 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 31-07-20 | ||
984 | |2 65 |1 01 |x 3/4 |a 3/15$000489050 | ||
985 | |2 65 |1 01 |x 3/4 |a 4/2019/01288 | ||
985 | |2 2002 |1 01 |x DE-21-123 |a B2021/131 | ||
998 | |2 2002 |1 01 |x DE-21-123 |0 2108 |